If so, how can DEA consider effective use, iddle time of the product, time while damaged, time while misused, while stored, while not reentering to a new consumption or reprocessing cycle?
Very interesting issue.I think that considering the widespread use that DEA has had in the last decade, it could be possible to adapt it for efficiency analysis of reverse logistic products. In my opinion the indicators mentioned could be used, with emphasis on time while damaged, time while misused, while not reentering a consumption or reprocessing cycle and other metrics related to the strategies adopted in the reverse logistic. It is also to be consider new circular approaches to manage end of life cycles and products. Regards
Dear Arialys, thanks for your considerations. Behind the question stands an idea of changing valuation accordingly the material-energetic situation of the good, and accordingly the demand. I think that such aspects are currently overlooked in research of medicines RL and CE, as most of published research focuses on RL optimisation taking few echelonsof the supply chain as analysis.